| CAS NO: | 54261-98-2 |
| 包装 | 价格(元) |
| 250mg | 电议 |
| 500mg | 电议 |
| 1 g | 电议 |
| 5 g | 电议 |
| Cas No. | 54261-98-2 |
| 别名 | 水苏糖 |
| Canonical SMILES | OC[C@]1(O[C@@H]([C@H]([C@@H]1O)O)CO)O[C@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO[C@H]3O[C@@H]([C@@H]([C@@H]([C@H]3O)O)O)CO[C@H]4O[C@@H]([C@@H]([C@@H]([C@H]4O)O)O)CO.O |
| 分子式 | C24H42O21·XH2O |
| 分子量 | 666.6 |
| 溶解度 | DMSO: 1 mg/ml,PBS (pH 7.2): 10 mg/ml |
| 储存条件 | -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Stachyose is an oligosaccharide and prebiotic.1,2,3In vivo, stachyose (1 g/kg per day) reduces the number of colonic lesions and serum TNF-α, IL-6, IL-10, and IL-17a levels, as well as increases gut levels ofAkkermansiaand the probioticLactobacillus, in a rat model of colitis induced by dextran sulfate .1It decreases serum LPS, IL-6, and TNF-α levels and enrichesPhascolarctobacterium,Bilophila,Oscillospira, andTuricibacterin the gut microbiota in a rat model of diabetes induced by high-fat diet and streptozotocin .2Stachyose also enhances berberine-induced blood glucose control and improvements in insulin resistance, as well as decreases the fecal concentration of short-chain fatty acids, in the KKAγ mouse model of type 2 diabetes.3 1.He, L., Zhang, F., Jian, Z., et al.Stachyose modulates gut microbiota and alleviates dextran sulfate sodium-induced acute colitis in miceSaudi J. Gastroenterol.26(3)153-159(2020) 2.Liu, G., Bei, J., Liang, L., et al.Stachyose improves inflammation through modulating gut microbiota of high-fat diet/streptozotocin-induced type 2 diabetes in ratsMol. Nutr. Food Res.62(6)e1700954(2018) 3.Cao, H., Li, C., Lei, L., et al.Stachyose improves the effects of berberine on glucose metabolism by regulating intestinal microbiota and short-chain fatty acids in spontaneous type 2 diabetic KKAy miceFront. Pharmacol.11578943(2020) |
m.cnreagent.com